Blue Box Medical Limited - Accounts to registrar (filleted) - small 18.2

Blue Box Medical Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v20.2.0.366 05306459 Board of Directors 1.1.19 31.12.19 31.12.19 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure053064592018-12-31053064592019-12-31053064592019-01-012019-12-31053064592017-12-31053064592018-01-012018-12-31053064592018-12-3105306459ns16:EnglandWales2019-01-012019-12-3105306459ns15:PoundSterling2019-01-012019-12-3105306459ns11:Director12019-01-012019-12-3105306459ns11:PrivateLimitedCompanyLtd2019-01-012019-12-3105306459ns11:SmallEntities2019-01-012019-12-3105306459ns11:AuditExempt-NoAccountantsReport2019-01-012019-12-3105306459ns11:SmallCompaniesRegimeForDirectorsReport2019-01-012019-12-3105306459ns11:SmallCompaniesRegimeForAccounts2019-01-012019-12-3105306459ns11:FullAccounts2019-01-012019-12-3105306459ns11:Director22019-01-012019-12-3105306459ns11:Director32019-01-012019-12-3105306459ns11:CompanySecretary12019-01-012019-12-3105306459ns11:RegisteredOffice2019-01-012019-12-3105306459ns6:CurrentFinancialInstruments2019-12-3105306459ns6:CurrentFinancialInstruments2018-12-3105306459ns6:Non-currentFinancialInstruments2019-12-3105306459ns6:Non-currentFinancialInstruments2018-12-3105306459ns6:ShareCapital2019-12-3105306459ns6:ShareCapital2018-12-3105306459ns6:SharePremium2019-12-3105306459ns6:SharePremium2018-12-3105306459ns6:RetainedEarningsAccumulatedLosses2019-12-3105306459ns6:RetainedEarningsAccumulatedLosses2018-12-3105306459ns6:LeaseholdImprovements2018-12-3105306459ns6:PlantMachinery2018-12-3105306459ns6:FurnitureFittings2018-12-3105306459ns6:ComputerEquipment2018-12-3105306459ns6:LeaseholdImprovements2019-01-012019-12-3105306459ns6:PlantMachinery2019-01-012019-12-3105306459ns6:FurnitureFittings2019-01-012019-12-3105306459ns6:ComputerEquipment2019-01-012019-12-3105306459ns6:LeaseholdImprovements2019-12-3105306459ns6:PlantMachinery2019-12-3105306459ns6:FurnitureFittings2019-12-3105306459ns6:ComputerEquipment2019-12-3105306459ns6:LeaseholdImprovements2018-12-3105306459ns6:PlantMachinery2018-12-3105306459ns6:FurnitureFittings2018-12-3105306459ns6:ComputerEquipment2018-12-3105306459ns6:CurrentFinancialInstrumentsns6:WithinOneYear2019-12-3105306459ns6:CurrentFinancialInstrumentsns6:WithinOneYear2018-12-310530645912019-01-012019-12-31
REGISTERED NUMBER: 05306459 (England and Wales)












BLUE BOX MEDICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2019






BLUE BOX MEDICAL LIMITED (REGISTERED NUMBER: 05306459)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


BLUE BOX MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2019







DIRECTORS: M Pedley
J Adamson
M C Coleman



SECRETARY: E K Harrison



REGISTERED OFFICE: Unit 29, New Forest Enterprise Centre
Rushington Business Park
Chapel Lane
Totton
Hampshire
SO40 9LA



REGISTERED NUMBER: 05306459 (England and Wales)



BANKERS: Lloyds TSB Bank plc
30 Commercial Road
Totton
Southampton
Hampshire
SO40 3TH

BLUE BOX MEDICAL LIMITED (REGISTERED NUMBER: 05306459)

BALANCE SHEET
31 DECEMBER 2019

2019 2018
Notes £    £   
FIXED ASSETS
Tangible assets 4 17,016 11,824

CURRENT ASSETS
Stocks 190,944 227,079
Debtors 5 254,508 439,036
Cash at bank and in hand 11,795 9,310
457,247 675,425
CREDITORS
Amounts falling due within one year 6 (948,449 ) (955,968 )
NET CURRENT LIABILITIES (491,202 ) (280,543 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(474,186

)

(268,719

)

CREDITORS
Amounts falling due after more than one
year

7

(85,470

)

(91,470

)
NET LIABILITIES (559,656 ) (360,189 )

CAPITAL AND RESERVES
Called up share capital 43,334 43,334
Share premium 5,000 5,000
Retained earnings (607,990 ) (408,523 )
SHAREHOLDERS' FUNDS (559,656 ) (360,189 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

BLUE BOX MEDICAL LIMITED (REGISTERED NUMBER: 05306459)

BALANCE SHEET - continued
31 DECEMBER 2019


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 September 2020 and
were signed on its behalf by:





M Pedley - Director


BLUE BOX MEDICAL LIMITED (REGISTERED NUMBER: 05306459)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019


1. STATUTORY INFORMATION

Blue Box Medical Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with FRS 102 "The Financial Reporting Standards
applicable in the UK and Republic of Ireland" ("FRS 102") and the requirements of the Companies Act 2006 as
applicable to companies subject to the small companies' regime.

The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure
is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary
amounts in these financial statements are rounded to the nearest £1.

The financial statements have been prepared under the historical cost convention, modified to include certain
financial instruments at fair value. The principal accounting policies adopted are set out below.

Going concern
Due to the nature of the company's trading activities, the impact of COVID-19 has resulted in a significant upturn
in performance since the year end, to the extent that the company is currently reflecting net assets in excess of
£200,000 at the date of signing of these financial statements.

Turnover
Turnover represents sales of goods net of VAT and trade discounts. Turnover is recognised when the goods are
physically dispatched to the customer.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Improvements to property - 3 years straight line
Computer Equipment - 2 years straight line
Office Equipment - 1 or 3 years straight line
Warehouse Equipment - 3 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and
the carrying value of the asset and is recognised in the income statement.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at
the date of transaction. Exchange differences are taken into account in arriving at profit before taxation.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

BLUE BOX MEDICAL LIMITED (REGISTERED NUMBER: 05306459)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2019


2. ACCOUNTING POLICIES - continued

Leasing commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over period
of the lease.

Financial assets
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12
'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial assets are recognised in the company's statement of financial position when the company becomes
party to the contractual provisions of the instrument.

Basic financial assets, which include trade and other receivables and cash and bank balances are initially
measured at transaction price including transaction costs and are subsequently carried at amortised cost using the
effective interest method, unless the arrangement constitutes a financial transaction, where the transaction is
measured at the present value of the future receipts discounted at a market rate of interest.

Financial liabilities
Basic financial liabilities, which include trade and other payables, are initially measured at transaction price and
subsequently measured at amortised cost, unless the arrangement constitutes a financing transaction where the
debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Equity instruments
Equity instruments issued by the company are recorded at the fair value of the proceeds received net of direct
issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the
discretion of the company.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2018 - 14 ) .

BLUE BOX MEDICAL LIMITED (REGISTERED NUMBER: 05306459)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2019


4. TANGIBLE FIXED ASSETS
Improvements
to Warehouse Office Computer
property equipment equipment equipment Totals
£    £    £    £    £   
COST
At 1 January 2019 12,102 2,086 20,891 81,984 117,063
Additions 3,200 - 5,141 10,604 18,945
Disposals - (1,130 ) (12,676 ) (58,465 ) (72,271 )
At 31 December 2019 15,302 956 13,356 34,123 63,737
DEPRECIATION
At 1 January 2019 12,102 1,286 14,607 77,244 105,239
Charge for year 497 192 3,524 8,351 12,564
Eliminated on disposal - (1,130 ) (11,487 ) (58,465 ) (71,082 )
At 31 December 2019 12,599 348 6,644 27,130 46,721
NET BOOK VALUE
At 31 December 2019 2,703 608 6,712 6,993 17,016
At 31 December 2018 - 800 6,284 4,740 11,824

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Trade debtors 205,886 239,209
Other debtors 48,622 199,827
254,508 439,036

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Trade creditors 664,914 638,601
Taxation and social security 40,716 84,867
Other creditors 242,819 232,500
948,449 955,968

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2019 2018
£    £   
Other creditors 85,470 91,470

BLUE BOX MEDICAL LIMITED (REGISTERED NUMBER: 05306459)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2019


8. SECURED DEBTS

The following secured debts are included within creditors:

2019 2018
£    £   
Other creditors 183,586 197,078

The trade invoice financing account is secured by way of an all assets debenture.

9. POST BALANCE SHEET EVENTS

COVID-19 and its effects on the business represent a non-adjusting post balance sheet event.

Due to the nature of the company's trading activities, the impact of COVID-19 has resulted in a significant upturn
in performance since the year end, to the extent that the net liabilities have been cleared in full prior to the date of
signing of these financial statements.